BACKGROUND: Genetic and pharmacological evidence suggests that the cyclic adenosine monophosphate-dependent protein kinase A pathway modulates neurobiological responses to ethanol. Mutant mice lacking the RIIbeta subunit of protein kinase A (RIIbeta(-/-)) are resistant to ethanol-induced sedation and drink significantly more ethanol than littermate wild-type mice (RIIbeta(+/+)). We determined whether high ethanol intake by the RIIbeta(-/-) mice on alternate genetic backgrounds is reliably predicted by high basal levels of anxiety or resistance to the sedative effects of ethanol. METHODS: Two-bottle choice procedures and a battery of behavioral tests (elevated plus maze, open-field activity, and zero maze) were used to assess voluntary ethanol consumption and basal levels of anxiety in RIIbeta(-/-) and RIIbeta(+/+) mice on either a C57BL/6J or a 129/SvEv x C57BL/6J genetic background. Additionally, ethanol-induced sedation and blood ethanol levels were determined in RIIbeta(-/-) and RIIbeta(+/+) mice after intraperitoneal injection of ethanol (3.8 g/kg). RESULTS: RIIbeta(-/-) mice on both genetic backgrounds consumed more ethanol and had a greater preference for ethanol relative to RIIbeta(+/+) mice. However, RIIbeta(-/-) mice showed reduced basal levels of anxiety when maintained on the C57BL/6J background but showed increased anxiety when maintained on the 129/SvEv x C57BL/6J background. Consistent with prior research, RIIbeta(-/-) mice were resistant to the sedative effects of ethanol, regardless of the genetic background. Finally, RIIbeta(-/-) and RIIbeta(+/+) mice showed similar blood ethanol levels. CONCLUSIONS: These results indicate that high ethanol consumption is associated with resistance to the sedative effects of ethanol but that basal levels of anxiety, as well as ethanol metabolism, do not reliably predict high ethanol drinking by RIIbeta(-/-) mice.
BACKGROUND: Genetic and pharmacological evidence suggests that the cyclic adenosine monophosphate-dependent protein kinase A pathway modulates neurobiological responses to ethanol. Mutant mice lacking the RIIbeta subunit of protein kinase A (RIIbeta(-/-)) are resistant to ethanol-induced sedation and drink significantly more ethanol than littermate wild-type mice (RIIbeta(+/+)). We determined whether high ethanol intake by the RIIbeta(-/-) mice on alternate genetic backgrounds is reliably predicted by high basal levels of anxiety or resistance to the sedative effects of ethanol. METHODS: Two-bottle choice procedures and a battery of behavioral tests (elevated plus maze, open-field activity, and zero maze) were used to assess voluntary ethanol consumption and basal levels of anxiety in RIIbeta(-/-) and RIIbeta(+/+) mice on either a C57BL/6J or a 129/SvEv x C57BL/6J genetic background. Additionally, ethanol-induced sedation and blood ethanol levels were determined in RIIbeta(-/-) and RIIbeta(+/+) mice after intraperitoneal injection of ethanol (3.8 g/kg). RESULTS:RIIbeta(-/-) mice on both genetic backgrounds consumed more ethanol and had a greater preference for ethanol relative to RIIbeta(+/+) mice. However, RIIbeta(-/-) mice showed reduced basal levels of anxiety when maintained on the C57BL/6J background but showed increased anxiety when maintained on the 129/SvEv x C57BL/6J background. Consistent with prior research, RIIbeta(-/-) mice were resistant to the sedative effects of ethanol, regardless of the genetic background. Finally, RIIbeta(-/-) and RIIbeta(+/+) mice showed similar blood ethanol levels. CONCLUSIONS: These results indicate that high ethanol consumption is associated with resistance to the sedative effects of ethanol but that basal levels of anxiety, as well as ethanol metabolism, do not reliably predict high ethanol drinking by RIIbeta(-/-) mice.
Authors: Andrey E Ryabinin; Agustin Galvan-Rosas; Ryan K Bachtell; Fred O Risinger Journal: Psychopharmacology (Berl) Date: 2002-11-20 Impact factor: 4.530
Authors: E P Brandon; S F Logue; M R Adams; M Qi; S P Sullivan; A M Matsumoto; D M Dorsa; J M Wehner; G S McKnight; R L Idzerda Journal: J Neurosci Date: 1998-05-15 Impact factor: 6.167
Authors: C W Hodge; K K Mehmert; S P Kelley; T McMahon; A Haywood; M F Olive; D Wang; A M Sanchez-Perez; R O Messing Journal: Nat Neurosci Date: 1999-11 Impact factor: 24.884
Authors: Frank M Ferraro; Dennis R Sparta; Darin J Knapp; George R Breese; Todd E Thiele Journal: Alcohol Clin Exp Res Date: 2006-05 Impact factor: 3.455
Authors: Simon Alex Marshall; Jennifer A Rinker; Langston K Harrison; Craig A Fletcher; Tina M Herfel; Todd E Thiele Journal: Alcohol Clin Exp Res Date: 2015-06-25 Impact factor: 3.455
Authors: Richard L Hauger; Victoria Risbrough; Olaf Brauns; Frank M Dautzenberg Journal: CNS Neurol Disord Drug Targets Date: 2006-08 Impact factor: 4.388
Authors: S Alex Marshall; Kyle H McKnight; Allyson K Blose; Donald T Lysle; Todd E Thiele Journal: J Neuroimmune Pharmacol Date: 2016-09-17 Impact factor: 4.147
Authors: Stephen L Carlson; Todd K O'Buckley; Rhiannon Thomas; Todd E Thiele; A Leslie Morrow Journal: Neurochem Res Date: 2013-10-09 Impact factor: 3.996